An Extension of CTN 31GB0607 to Evaluate Long Term Safety of NASHA Treatment in the Breast

The study evaluates degradation of NASHA in breast 4 and 6 years post treatment, long term safety and evaluation if a satisfactory breast cancer screening can be performed in subjects treated with NASHA-gel in breast. An independent evaluation of the aesthetic changes is also performed.

Inclusion Criteria:

• subject treated with NASHA-gel in the breasts in study 31GB0607
• signed informed consent

Exclusion Criteria:

• no exclusion criteria in this study